Abiopharma

Clinical trial NCT06692738 updates: 1. completion date: 2029-10-08 → 2030-07-01 2. primary completion date: 2029-02-05 → 2030-07-01 3. enrollment: 880 → 1160 participants

Clinical trial NCT06007937 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 56 → 9 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06389513 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2026-05-01 3. primary completion date: 2025-12-01 → 2026-04-10

Clinical trial NCT04220073 updates: 1. status: UNKNOWN → COMPLETED 2. start date: 2020-01-05 → 2020-05-17 3. completion date: 2021-01-17 → 2020-11-20 4. primary completion date: 2020-09-21 → 2020-11-20 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07271251 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-03 → 2026-08-04 3. enrollment: 264 → 267 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07484230 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 20 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07552558 updates: 1. start date: 2026-06-30 → 2026-09-30 2. completion date: 2033-08-31 → 2033-11-30 3. primary completion date: 2028-08-31 → 2028-11-30

Clinical trial NCT07593092 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-30

Clinical trial NCT03409432: collaborators added: Celgene Corporation.

Clinical trial NCT07265258 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-30 → 2026-07-30 3. completion date: 2027-09-04 → 2028-12-30 4. primary completion date: 2026-09-12 → 2028-06-30